Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 91.88M
June 30, 2026 91.88M
March 31, 2026 91.88M
December 31, 2025 91.88M
September 30, 2025 91.88M
June 30, 2025 89.70M
March 31, 2025 89.70M
December 31, 2024 89.70M
September 30, 2024 75.00M
June 30, 2024 75.00M
March 31, 2024 15.97M
December 31, 2023 15.97M
September 30, 2023 15.97M
Date Value
June 30, 2023 15.97M
March 31, 2023 15.97M
December 31, 2022 15.97M
September 30, 2022 15.97M
June 30, 2022 15.97M
March 31, 2022 15.97M
December 31, 2021 15.97M
September 30, 2021 10.96M
June 30, 2021 10.96M
March 31, 2021 10.96M
September 30, 2020 10.96M
June 30, 2020 10.96M
March 31, 2020 10.96M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
EyePoint, Inc. 90.77M
Neumora Therapeutics, Inc. 188.69M
LENZ Therapeutics, Inc. 31.42M
ANI Pharmaceuticals, Inc. 22.90M
Corcept Therapeutics, Inc. 109.36M